Prostatype Genomics (Sweden) Analysis
| PROGEN Stock | SEK 3.30 0.58 14.95% |
Prostatype Genomics AB is overvalued with Real Value of 3.17 and Hype Value of 3.3. The main objective of Prostatype Genomics stock analysis is to determine its intrinsic value, which is an estimate of what Prostatype Genomics AB is worth, separate from its market price. There are two main types of Prostatype Genomics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Prostatype Genomics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Prostatype Genomics' stock to identify patterns and trends that may indicate its future price movements.
The Prostatype Genomics stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Prostatype Genomics' ongoing operational relationships across important fundamental and technical indicators.
Prostatype |
Prostatype Stock Analysis Notes
About 13.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.14. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prostatype Genomics recorded a loss per share of 1.22. The entity had not issued any dividends in recent years. The firm had 1000:1 split on the 31st of October 2024. Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. The company was founded in 2007 and is based in Solna, Sweden. Prostatype Genomics is traded on Stockholm Stock Exchange in Sweden. To find out more about Prostatype Genomics AB contact Fredrik Persson at 46 08 20 87 00 or learn more at https://www.prostatypegenomics.com.Prostatype Genomics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Prostatype Genomics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Prostatype Genomics AB or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Prostatype Genomics generated a negative expected return over the last 90 days | |
| Prostatype Genomics has high historical volatility and very poor performance | |
| The company reported the revenue of 10 K. Net Loss for the year was (15.63 M) with loss before overhead, payroll, taxes, and interest of (5.98 M). | |
| Prostatype Genomics AB has accumulated about 7.66 M in cash with (16.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. |
Prostatype Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prostatype Genomics's market, we take the total number of its shares issued and multiply it by Prostatype Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of March, Prostatype Genomics holds the Risk Adjusted Performance of (0.20), coefficient of variation of (402.16), and Variance of 42.1. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prostatype Genomics, as well as the relationship between them.Prostatype Genomics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Prostatype Genomics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Prostatype Genomics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Prostatype Genomics Outstanding Bonds
Prostatype Genomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Prostatype Genomics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Prostatype bonds can be classified according to their maturity, which is the date when Prostatype Genomics AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Prostatype Genomics Predictive Daily Indicators
Prostatype Genomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Prostatype Genomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Prostatype Genomics Forecast Models
Prostatype Genomics' time-series forecasting models are one of many Prostatype Genomics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prostatype Genomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Prostatype Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Prostatype Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prostatype shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Prostatype Genomics. By using and applying Prostatype Stock analysis, traders can create a robust methodology for identifying Prostatype entry and exit points for their positions.
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. The company was founded in 2007 and is based in Solna, Sweden. Prostatype Genomics is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Prostatype Genomics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Complementary Tools for Prostatype Stock analysis
When running Prostatype Genomics' price analysis, check to measure Prostatype Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prostatype Genomics is operating at the current time. Most of Prostatype Genomics' value examination focuses on studying past and present price action to predict the probability of Prostatype Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prostatype Genomics' price. Additionally, you may evaluate how the addition of Prostatype Genomics to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |